Compounds of the formula ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 is aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl, heterocycloalkylalkyl or alkyl, all optionally substituted; R.sup.2 is H; or aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl, heterocycloalkylalkyl or alkyl, all optionally substituted; R.sup.3 is aryl, heteroaryl, cycloalkyl or heterocycloalkyl, all optionally substituted; X is a bond, --(CH.sub.2).sub.m--N(R.sup.7)--(CH.sub.2).sub.n--, --(CH.sub.2).sub.m--O--(CH.sub.2).sub.n--, --(CH.sub.2).sub.m--S--CH.sub.2).sub.n--, --C(O)--, --CH(OH)--, --C(O)N(R.sup.7)--, --C(O)N(R.sup.7)-alkylene or --N(R.sup.7)C(O)--; R.sup.7 is H or alkyl; and m and n are each 0-6, provided that the sum of m and n is 0-6; or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical compositions thereof, and the use of said compounds in the treatment of cough, pain, anxiety, asthma, depression, alcohol abuse, urinary incontinence and overactive bladder are disclosed.

 
Web www.patentalert.com

< Selected CGRP--antagonists, process for preparing them and their use as pharmaceutical compositions

> Force switch

~ 00492